PROCEPT BioRobotics Announces Two Milestones In Its WATER IV Prostate Cancer Clinical Program
PROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
Procept (PRCT) Q1 2026 Earnings Transcript
Piper Sandler Reiterates Overweight on PROCEPT BioRobotics, Raises Price Target to $35
PROCEPT BioRobotics Corporation Q1 2026 Earnings Call Summary
PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...
PROCEPT BioRobotics Corporation (PRCT) Q1 2026 Earnings Call Transcript
PROCEPT BioRobotics Q1 Earnings Call Highlights
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) Q1 Earnings Beat Drives 13% Surge Despite Net Loss
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $396.674M Est
PROCEPT BioRobotics Q1 EPS $(0.56), Inline, Sales $83.132M Beat $80.506M Estimate
PROCEPT BioRobotics (PRCT) Earnings Transcript
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?
Procept BioRobotics: An Undervalued Surgical Robotics Growth Story
EAU Upgrade Puts Aquablation And PROCEPT BioRobotics In Focus
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.